Actively Recruiting
Prospective Multicenter Observational Study Evaluating Salvage High-Dose-Rate Brachytherapy for Locally Recurrent Prostate Cancer Diagnosed by Advanced Imaging and Biopsy
Led by Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic · Updated on 2026-10-09
63
Participants Needed
10
Research Sites
12 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to analyze salvage treatment for patients with locally recurrent prostate cancer diagnosed through advanced imaging techniques such as choline PET, PSMA PET, and MRI, along with confirmed biopsy results. The study is observational and multicenter, focusing on patients who previously received radical-intent radiotherapy and are now scheduled for salvage treatment. The primary objective is to evaluate biochemical relapse-free survival and study the toxicities and quality of life impacts of this approach. Patients will undergo two fractions of high-dose-rate HDR brachytherapy as salvage treatment following initial radiotherapy. The salvage brachytherapy is part of routine clinical practice and is assessed through biochemical markers and imaging. Participants are followed for up to four years, with evaluations every six months to monitor treatment effects and disease status. During the study, participants will have regular assessments including imaging to detect local relapse, toxicity evaluations using standardized criteria, and quality of life questionnaires such as IPSS, FACT-P, and EORTC QLQ-PR25. Monitoring includes acute and chronic toxicity evaluations and tracking biochemical relapse-free survival for up to 48 months. The study involves a 2-year recruitment period with follow-up visits every six months over four years, ensuring ongoing observation of treatment outcomes and patient well-being.
CONDITIONS
Brief Title
Study on Prostate Salvage Using High-dose-rate Brachytherapy
Research Team
P
Patricia Willisch Santamaría, MD PhD
P
Pablo Raña Díez
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here